AMM is the preeminent source of mRNA studies and data. In addition to publishing original research on the state of mRNA worldwide, we serve as an aggregator of the latest studies from the field. Explore below to learn more about recent advancements in mRNA technology.
The therapeutic use of messenger RNA (mRNA) has fueled great hope to combat a wide range of incurable diseases. Recent rapid advances in biotechnology and molecular medicine have enabled the production of almost any functional protein/peptide in the human body by introducing mRNA as a vaccine or therapeutic agent.
COVID-19 mRNA vaccines: Platforms and current developments
Since the first successful application of messenger ribonucleic acid (mRNA) as a vaccine agent in a preclinical study nearly 30 years ago, numerous advances have been made in the field of mRNA therapeutic technologies.
Clinical advances and ongoing trials of mRNA vaccines for cancer treatment
Years of research exploring mRNA vaccines for cancer treatment in preclinical and clinical trials have set the stage for the rapid development of mRNA vaccines during the COVID-19 pandemic.
Current Status and Future Perspectives on MRNA Drug Manufacturing
The COVID-19 pandemic has catapulted mRNA (mRNA)vaccines from a relatively niche technology into the mainstream, with several hundred million doses of mRNA vaccines being administered.